Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for bone marrow edema syndrome
2010-019415-38Phase 3Completed
- Sponsor
- University Hospital Würzburg
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bone marrow edema syndrome (BMES) comparing Zoledronic acid with Placebo (2 arms). Started Nov 2010; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone marrow edema syndrome (BMES)
Beyond the preview
Go deeper on 2010-019415-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019415-38.